Biofarma Group (Ardian) acquires US Pharma Lab
Milan, May 18th 2023 – Biofarma Group, controlled by Ardian together with the Scarpa family, has entered into a definitive agreement for the acquisition of 100% of US Pharma Lab, Inc. from its Founder and Chairman, Mr. Ashok Luhadia, its CEO, Mr. Amol Luhadia, as well as other members of the Luhadia family. To cement a partnership between Ardian, the Scarpa family and the Luhadia family, the current shareholders of US Pharma Lab will reinvest a significant portion of their proceeds into an indirect parent company of Biofarma Group.
Sheppard Mullin has assisted US Pharma Lab, Inc. and the sellers, including Founder and Chairman, Mr. Ashok Luhadia, CEO, Mr. Amol Luhadia, as well as other members of the Luhadia family. The Sheppard Mullin team was led by Partner Ariel Yehezkel, Special Counsel Amanda S. Ackerman and Associate Allison Troianos.
Pavia e Ansaldo, with Partners Roberto Zanchi and Carlo Trucco, advised the sellers for Italian law aspects